Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07454850) titled 'A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait' on March 3.
Study Type: Observational
Primary Sponsor: Novartis Pharmaceuticals
Condition:
Leukemia, Myeloid, Chronic-Phase
Recruitment Status: Not recruiting
Date of First Enrollment: March 17, 2026
Target Sample Size: 400
To know more, visit https://clinicaltrials.gov/study/NCT07454850
Disclaimer: Curated by HT Syndication....